[DPHARMA] QoQ TTM Result on 30-Jun-2020 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
13-Aug-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
30-Jun-2020 [#2]
Profit Trend
QoQ- 1.5%
YoY- 0.27%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Revenue 577,643 569,902 573,571 582,654 584,789 576,462 554,341 2.78%
PBT 81,606 76,157 69,625 70,825 69,750 70,809 74,528 6.22%
Tax -18,943 -17,547 -15,175 -15,643 -15,381 -15,536 -16,919 7.81%
NP 62,663 58,610 54,450 55,182 54,369 55,273 57,609 5.76%
-
NP to SH 62,663 58,610 54,450 55,182 54,369 55,273 57,609 5.76%
-
Tax Rate 23.21% 23.04% 21.80% 22.09% 22.05% 21.94% 22.70% -
Total Cost 514,980 511,292 519,121 527,472 530,420 521,189 496,732 2.43%
-
Net Worth 635,424 642,484 584,565 581,725 540,662 525,364 505,919 16.39%
Dividend
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Div 45,783 45,783 37,536 37,536 40,733 40,733 33,094 24.13%
Div Payout % 73.06% 78.12% 68.94% 68.02% 74.92% 73.69% 57.45% -
Equity
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Net Worth 635,424 642,484 584,565 581,725 540,662 525,364 505,919 16.39%
NOSH 706,026 706,026 706,026 684,383 684,383 684,383 680,106 2.52%
Ratio Analysis
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
NP Margin 10.85% 10.28% 9.49% 9.47% 9.30% 9.59% 10.39% -
ROE 9.86% 9.12% 9.31% 9.49% 10.06% 10.52% 11.39% -
Per Share
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
RPS 81.82 80.72 82.42 85.14 85.45 84.49 82.18 -0.29%
EPS 8.88 8.30 7.82 8.06 7.94 8.10 8.54 2.63%
DPS 6.48 6.48 5.50 5.50 5.95 5.97 5.00 18.85%
NAPS 0.90 0.91 0.84 0.85 0.79 0.77 0.75 12.91%
Adjusted Per Share Value based on latest NOSH - 684,383
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
RPS 60.01 59.20 59.58 60.53 60.75 59.88 57.58 2.79%
EPS 6.51 6.09 5.66 5.73 5.65 5.74 5.98 5.81%
DPS 4.76 4.76 3.90 3.90 4.23 4.23 3.44 24.14%
NAPS 0.6601 0.6674 0.6072 0.6043 0.5616 0.5457 0.5255 16.40%
Price Multiplier on Financial Quarter End Date
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Date 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 -
Price 2.75 3.38 3.16 1.62 1.39 1.42 1.40 -
P/RPS 3.36 4.19 3.83 1.90 1.63 1.68 1.70 57.42%
P/EPS 30.98 40.72 40.39 20.09 17.50 17.53 16.39 52.81%
EY 3.23 2.46 2.48 4.98 5.72 5.70 6.10 -34.52%
DY 2.36 1.92 1.74 3.40 4.28 4.20 3.57 -24.09%
P/NAPS 3.06 3.71 3.76 1.91 1.76 1.84 1.87 38.82%
Price Multiplier on Announcement Date
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Date 03/05/21 22/02/21 12/11/20 13/08/20 18/05/20 13/02/20 29/11/19 -
Price 2.93 3.42 4.04 3.15 1.72 1.64 1.39 -
P/RPS 3.58 4.24 4.90 3.70 2.01 1.94 1.69 64.86%
P/EPS 33.01 41.20 51.63 39.07 21.65 20.24 16.28 60.13%
EY 3.03 2.43 1.94 2.56 4.62 4.94 6.14 -37.52%
DY 2.21 1.90 1.36 1.75 3.46 3.64 3.60 -27.74%
P/NAPS 3.26 3.76 4.81 3.71 2.18 2.13 1.85 45.84%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment